The Ford F-150 Lightning displayed at the Philadelphia Auto Show on Jan. 27, 2023, in Philadelphia. Ford says it’s reducing production of the F-150 Lightning electric pickup vehicle as it adjusts to weaker-than-expected electric vehicle sales growth. (AP Photo/Matt Rourke, File)
Ford is cutting production of the F-150 Lightning electric pickup after weaker-than-expected electric vehicle sales growth.
Ford said that about 1,400 workers will be impacted by the move to lower F-150 Lightning production, with the Rouge Electric Vehicle Center transitioning to one shift, effective April 1. Approximately 700 employees will transfer to Ford's Michigan assembly plant while other workers will be placed in roles at the Rouge Complex or other facilities in Southeast Michigan. Some employees are expected to take advantage of the Special Retirement Incentive Program agreed to in the 2023 Ford-UAW contract.
Ford said a few dozen employees could be impacted at component plants supporting F-150 Lightning production, depending on how many workers apply for the retirement program. The company said it would provide placements for impacted employees within Southeast Michigan.
Ford also said Friday that it's creating almost 900 new jobs and adding a third crew at its Michigan assembly plant to meet demand for the Bronco and Bronco Raptor and the all-new Ranger and Ranger Raptor.
Smoke that filled the cabin of a Delta flight as it took off from the Atlanta airport in February was so thick the led flight attendant had trouble seeing past the first row of passengers and the pilots donned oxygen masks as a precaution.
Arjan Stephens, President of Nature's Path, discusses the company's origin, how it has evolved today and the interesting product that came from his wedding!
Small business reporter, Gene Marks, joins Cheddar to give analysis on how small businesses are tackling incoming tariffs and how it will affect the consumer.
Babylist CEO Natalie Gordon joins Cheddar to discuss how the website is helping new parents, how to make a registry and how secondhand options are available.
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.